JG
SBBP

Jefferies Group’s Strongbridge Biopharma plc. SBBP Stock Holding History

Jefferies Group’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-50,000
Closed -$157K – 3177
2019
Q2 		$157K Sell
50,000
-25,000
-33% -$91.8K ﹤0.01% 2204
2019
Q1 		$374K Buy
+75,000
New +$369K ﹤0.01% 1719

Other funds holding SBBP

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Jefferies Group's SBBP Position: Q3 2019 in Review

Jefferies Group sold out of Strongbridge Biopharma plc. (SBBP) in Q3 2019, closing a stake of 50,000 shares — an estimated $157K sold.

Jefferies Group first reported a position in SBBP in Q1 2019 and held it in 2 quarters. The position peaked at $374K in Q1 2019. 54 funds tracked by Wall St. Rank hold SBBP as of Q3 2019.

  • Jefferies Group reported no remaining Strongbridge Biopharma plc. position as of Q3 2019 after selling out during the quarter.
  • Jefferies Group sold 50,000 Strongbridge Biopharma plc. shares in Q3 2019, an estimated $157K.
  • Jefferies Group first reported a position in Strongbridge Biopharma plc. in Q1 2019 and held it in 2 quarters.
  • Jefferies Group's Strongbridge Biopharma plc. position peaked at $374K in Q1 2019.
  • 54 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q3 2019.

Based on Jefferies Group's 13F filing for Q3 2019, filed 13 Nov 2019.